Document Type

Article

Journal Title

Oncotarget

Publication Date

2-10-2015

Volume

6

Abstract

Amyloid precursor-like protein 2 (APLP2) is aberrantly expressed in pancreatic cancer. Here we showed that APLP2 is increased in pancreatic cancer metastases, particularly in metastatic lesions found in the diaphragm and intestine. Examination of matched human primary tumor-liver metastasis pairs showed that 38.1% of the patients had positive APLP2 expression in both the primary tumor and the corresponding liver metastasis. Stable knock-down of APLP2 expression (with inducible shRNA) in pancreatic cancer cells reduced the ability of these cells to migrate and invade. Loss of APLP2 decreased cortical actin and increased intracellular actin filaments in pancreatic cancer cells. Down-regulation of APLP2 decreased the weight and metastasis of orthotopically transplanted pancreatic tumors in nude mice.

MeSH Headings

Actin Cytoskeleton, Amyloid beta-Protein Precursor, Animals, Anti-Bacterial Agents, Cell Line, Tumor, Cell Movement, Cell Proliferation, Down-Regulation, Doxycycline, Female, Flow Cytometry, Humans, Immunoblotting, Immunohistochemistry, Liver Neoplasms, Lung Neoplasms, Mice, Nude, Nerve Tissue Proteins, Pancreatic Neoplasms, RNA Interference, Tumor Burden, Xenograft Model Antitumor Assays

ISSN

1949-2553

Creative Commons License

Creative Commons Attribution 3.0 License
This work is licensed under a Creative Commons Attribution 3.0 License.

Additional Files
Amyloid precursor supp. 1.pdf (647 kB)
Download
COinS